Skip to content
WeighLab
Menu
Ranked #251 · Grade C

VevaRX review

VevaRX sells compounded semaglutide at $189 a month and tirzepatide only as a $467 quarterly plan with a three-month minimum, on a site that prints at least eight mutually contradictory prices for its own products.

Visit VevaRX Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$189/month month-to-month (the same page also prints $167/month and a $467 three-month total)
Tirzepatide
$155.67/mo equivalent — VevaRX bills $467 every three months on a three-month minimum and publishes no monthly plan
Coverage
36 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,268

Tirzepatide · modeled / year

$1,860

Pricing verified September 2026

The Index scorecard

VevaRX scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month44/100
Price Transparency78/100
Nationwide Access66/100
Formulation Options66/100
Clinical Oversight60/100
Contract Flexibility43/100

Where the value is

  • Enumerates the 36 states it serves by name rather than making an unqualified nationwide claim
  • States what the tirzepatide price covers — the treatment, the supplies, the provider visit and two-to-three-day shipping
  • Publishes a monthly semaglutide option alongside the quarterly plan, which its tirzepatide program does not offer
  • Sets out its refund rule explicitly, including the 28-day window and the written-request requirement

The tradeoffs

  • The semaglutide page carries four prices, two of which belong to tirzepatide: $189 a month, $399 for three months, $167 a month and a $467 total
  • The tirzepatide page's own arithmetic is wrong — it calls $467 over three months "equivalent to $149 per month", when it is $155.67, a figure the semaglutide page states correctly
  • Tirzepatide has no monthly option at all: a three-month minimum, billed every three months and auto-renewing
  • The terms enumerate 36 states in the FAQ and twice assert availability across all 50
  • Another company's domain is live inside VevaRX's own terms, and the contact page's FAQ is a different product's copy — including dosing instructions telling a GLP-1 patient to mix a scoop of powder into water
  • Two opposite return policies are published: one page says shipped medication cannot be returned, another promises money back
  • No pharmacy, physician, NPI or medical group is named anywhere, and 503A and 503B appear zero times
  • The terms carry a fifth price ladder matching nothing on the site, in which the "original" price is lower than the current one
  • Three different prices are published for its NAD+ program on a single page, and the cart charges a different figure again for two others

The bottom line

Best for: Readers in one of the 36 states it names who will confirm the charge in writing before submitting an intake. VevaRX sells compounded semaglutide at $189 a month and tirzepatide only as a $467 quarterly plan with a three-month minimum, on a site that prints at least eight mutually contradictory prices for its own products.

Ranked #251 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to VevaRX.

The 24 programs nearest this one

Pricing, states and verification reflect VevaRX's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on VevaRX's site. Not medical advice; see our disclosure.

← Back to the value leaderboard